ABSTRACT
Industry 4.0 (I4.0) is the new paradigm shift impacting businesses today. This study explores the state of Bangladeshi family businesses in adapting to I4.0 using a qualitative research methodology. Top management personnel were interviewed to capture their insights on transitioning to I4.0. The thematic analysis revealed four themes, current state of the businesses, challenges faced, pandemic impact on human resources, and future plans. Findings indicate high awareness and greater adoption of digital practices with COVID-19 acting as a catalyst. Although training is emphasized, there is a lack of focus on both career and general counselling, which may prove to be detrimental in the future. The study takes a resource-based view to find the bundle of resources acting as conditions for the family firms to evolve into the I4.0, thereby making a practical contribution to understanding the role of family businesses in implementing I4.0 policies to enrich their human resource competencies and leverage the benefits of I4.0.
ABSTRACT
Background To delineate the clinico-epidemiological characteristics of pediatric coronavirus disease-2019 (COVID-19) patients was the objective of the study.Method: This observational study included 290 pediatric patients with a definite diagnosis of COVID-19 admitted to Dhaka Shishu Hospital, Bangladesh, from April 2021 to October 2021. Clinical and epidemiological characteristics were analyzed based on demographic data, medical history, laboratory tests, and outcome information. Data analysis was performed with SPSS 26. Ethical measures were taken in compliance with the current declaration of Helsinki, and final analysis was performed using SPSS 26.Result Of all, 42 (14.5%) were neonates (< 28 days), 88 (30.3%) were infants (28 days to < 1 year) and 160 (55.2%) were children (1–17 years). The median age of the children was 18 (0.3–204) months, 58.3% were male, 62% had malnutrition, and presented with various clinical presentations. The main symptoms were fever (5.7%) and breathlessness (20%). Approximately 22% of children were asymptomatic, and 57% had at least one comorbidity. Fever and abdominal pain were predominant presenting symptoms in children compared with neonates and infants (p < .01 for both), while cough and breathlessness were more frequent in infants (p < .01 for both). The infants suffered significantly from neutropenia and lymphocytosis than neonates and children (p < .001 for both). The discharge and death rates were 77.8% with 6.9%. Overall case fatality was higher among neonates than others.Conclusion Compared to other pediatric groups, neonatal case fatality was higher, and COVID-19 in neonates, infants, and children has similar epidemiological and clinical manifestations. The findings from this study might help to guide the development of measures to prevent and treat this ongoing global pandemic of these particular age groups.